Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea

OBJECTIVE: To compare the cost-effectiveness of conventional antimalarial therapy with that of three artemisinin combination treatment regimens in children from Papua New Guinea aged 6 to 60 months. METHODS: An incremental cost-effectiveness analysis was performed using data from 656 children with P...

Full description

Bibliographic Details
Main Authors: Wendy A Davis, Philip M Clarke, Peter M Siba, Harin A Karunajeewa, Carol Davy, Ivo Mueller, Timothy ME Davis
Format: Article
Language:English
Published: The World Health Organization
Series:Bulletin of the World Health Organization
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862011000300012&lng=en&tlng=en
_version_ 1797288077560905728
author Wendy A Davis
Philip M Clarke
Peter M Siba
Harin A Karunajeewa
Carol Davy
Ivo Mueller
Timothy ME Davis
author_facet Wendy A Davis
Philip M Clarke
Peter M Siba
Harin A Karunajeewa
Carol Davy
Ivo Mueller
Timothy ME Davis
author_sort Wendy A Davis
collection DOAJ
description OBJECTIVE: To compare the cost-effectiveness of conventional antimalarial therapy with that of three artemisinin combination treatment regimens in children from Papua New Guinea aged 6 to 60 months. METHODS: An incremental cost-effectiveness analysis was performed using data from 656 children with Plasmodium falciparum and/or P. vivax malaria who participated in a large intervention trial in two clinics in northern Papua New Guinea. The children were randomized to one of the following groups: (i) conventional treatment with chloroquine plus sulfadoxine plus pyrimethamine (CQ+S+P); (ii) artesunate plus S plus P; (iii) dihydroartemisinin plus piperaquine (DHA+PQ); and (iv) artemether plus lumefantrine (A+L). For treatment outcomes, World Health Organization definitions were used. The cost of transport between home and the clinic plus direct health-care costs served as a basis for determining each regimen's incremental cost per incremental treatment success relative to CQ+S+P by day 42 and its cost per life year saved. FINDINGS: A+L proved to be the most effective regimen against P. falciparum malaria and was highly cost-effective at 6.97 United States dollars (US$) per treatment success (about US$ 58 per life year saved). DHA+PQ was the most effective regimen against P. vivax malaria and was more cost-effective than CQ+S+P. CONCLUSION: A+L and DHA+PQ are highly cost-effective regimens for the treatment of paediatric P. falciparum and P. vivax malaria, respectively, in parts of Papua New Guinea. Future research will be required to determine if these findings hold true for other territories in Asia and Oceania with similar malaria epidemiology.
first_indexed 2024-03-07T18:44:07Z
format Article
id doaj.art-1253b7f3b9f2434dacc1ba5390063f90
institution Directory Open Access Journal
issn 0042-9686
language English
last_indexed 2024-03-07T18:44:07Z
publisher The World Health Organization
record_format Article
series Bulletin of the World Health Organization
spelling doaj.art-1253b7f3b9f2434dacc1ba5390063f902024-03-02T02:53:51ZengThe World Health OrganizationBulletin of the World Health Organization0042-968689321122010.2471/BLT.10.084103S0042-96862011000300012Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New GuineaWendy A Davis0Philip M Clarke1Peter M Siba2Harin A Karunajeewa3Carol Davy4Ivo Mueller5Timothy ME Davis6University of Western AustraliaUniversity of SydneyPapua New Guinea Institute of Medical ResearchUniversity of Western AustraliaUniversity of AdelaidePapua New Guinea Institute of Medical ResearchUniversity of Western AustraliaOBJECTIVE: To compare the cost-effectiveness of conventional antimalarial therapy with that of three artemisinin combination treatment regimens in children from Papua New Guinea aged 6 to 60 months. METHODS: An incremental cost-effectiveness analysis was performed using data from 656 children with Plasmodium falciparum and/or P. vivax malaria who participated in a large intervention trial in two clinics in northern Papua New Guinea. The children were randomized to one of the following groups: (i) conventional treatment with chloroquine plus sulfadoxine plus pyrimethamine (CQ+S+P); (ii) artesunate plus S plus P; (iii) dihydroartemisinin plus piperaquine (DHA+PQ); and (iv) artemether plus lumefantrine (A+L). For treatment outcomes, World Health Organization definitions were used. The cost of transport between home and the clinic plus direct health-care costs served as a basis for determining each regimen's incremental cost per incremental treatment success relative to CQ+S+P by day 42 and its cost per life year saved. FINDINGS: A+L proved to be the most effective regimen against P. falciparum malaria and was highly cost-effective at 6.97 United States dollars (US$) per treatment success (about US$ 58 per life year saved). DHA+PQ was the most effective regimen against P. vivax malaria and was more cost-effective than CQ+S+P. CONCLUSION: A+L and DHA+PQ are highly cost-effective regimens for the treatment of paediatric P. falciparum and P. vivax malaria, respectively, in parts of Papua New Guinea. Future research will be required to determine if these findings hold true for other territories in Asia and Oceania with similar malaria epidemiology.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862011000300012&lng=en&tlng=en
spellingShingle Wendy A Davis
Philip M Clarke
Peter M Siba
Harin A Karunajeewa
Carol Davy
Ivo Mueller
Timothy ME Davis
Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea
Bulletin of the World Health Organization
title Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea
title_full Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea
title_fullStr Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea
title_full_unstemmed Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea
title_short Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea
title_sort cost effectiveness of artemisinin combination therapy for uncomplicated malaria in children data from papua new guinea
url http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862011000300012&lng=en&tlng=en
work_keys_str_mv AT wendyadavis costeffectivenessofartemisinincombinationtherapyforuncomplicatedmalariainchildrendatafrompapuanewguinea
AT philipmclarke costeffectivenessofartemisinincombinationtherapyforuncomplicatedmalariainchildrendatafrompapuanewguinea
AT petermsiba costeffectivenessofartemisinincombinationtherapyforuncomplicatedmalariainchildrendatafrompapuanewguinea
AT harinakarunajeewa costeffectivenessofartemisinincombinationtherapyforuncomplicatedmalariainchildrendatafrompapuanewguinea
AT caroldavy costeffectivenessofartemisinincombinationtherapyforuncomplicatedmalariainchildrendatafrompapuanewguinea
AT ivomueller costeffectivenessofartemisinincombinationtherapyforuncomplicatedmalariainchildrendatafrompapuanewguinea
AT timothymedavis costeffectivenessofartemisinincombinationtherapyforuncomplicatedmalariainchildrendatafrompapuanewguinea